ARCHIVES

Phase III Regorafenib Trial Meets PFS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Alexion In Collaboration With Netherlands Center.

November 30, 2001

Centers Structures, Governance, Funding, Review considered By NCI, NCAB, Center Directors

September 30, 1977

Cancer Clinical Trials System Needs Comprehensive Review, NCI Director Says

July 11, 2003

NCAB Removes Its Restrictions On PDQ Access, Permits NCI Staff To Decide

February 7, 1986

Some Cancer Control Projects On Thin Ice As Board Eyes Funds For Others

January 29, 1982

Centers See Trend To Integrate Control Service With Science

February 18, 1983